Your session is about to expire
← Back to Search
Exercise--Rock Steady Boxing class for Parkinson's Disease (FIGHTPD Trial)
N/A
Recruiting
Led By Daniel Claassen, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participant agreeable to an overnight dopaminergic medication washout period
Participant is willing and able to participate in a Rock Steady Boxing class
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is designed to measure the change in patients diagnosed with Parkinson's disease before, during and after a 12 week exercise program, with a focus on the glymphatic system.
Eligible Conditions
- Parkinson's Disease
- Glymphatic System
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
6 Minute Walk Test
Brief Estimate of Seconds (BEST)
Change in Beta-Amyloid Levels
+11 moreSecondary study objectives
ActiGraphy
Neurametrix
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Exercise--Rock Steady Boxing classExperimental Treatment1 Intervention
Participants will be going twice a week to a Rock Steady Boxing class for an hour/class. Participants will be going to this class for a total of three months.
Find a Location
Who is running the clinical trial?
United States Department of DefenseFED
909 Previous Clinical Trials
333,664 Total Patients Enrolled
Vanderbilt University Medical CenterLead Sponsor
902 Previous Clinical Trials
938,788 Total Patients Enrolled
Daniel Claassen, MDPrincipal Investigator - Associate Professor
Vanderbilt University Hospital
Medical College Of Georgia School Of Medicine (Medical School)
Mayo Grad School Med/Mayo Fndn (Residency)
2 Previous Clinical Trials
115 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger